Header Logo

Connection

AMY B HEIMBERGER to Bevacizumab

Back to Details
This is a "connection" page, showing publications AMY B HEIMBERGER has written about Bevacizumab.
AMY B HEIMBERGER
Connection Strength
0.082
Bevacizumab
  1. Modulating antiangiogenic resistance by inhibiting the signal transducer and activator of transcription 3 pathway in glioblastoma. Oncotarget. 2012 Sep; 3(9):1036-48.
    View in: PubMed
    Score: 0.082
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.